1.Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya UNO ; Rie MATSUO ; Naoki MAEZAWA ; Tomoyasu KATO
Obstetrics & Gynecology Science 2023;66(4):290-299
Objective:
We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC).
Methods:
We included Japanese patients newly diagnosed with OC treated at the National Cancer Center Hospital between 2014 and 2021. The HE4 levels were measured in the serum stored during diagnosis. To evaluate the concordance between HE4 and the imaging results, we employed sequential pairs of blood sampling points and the results of imaging examinations. We compared the timing of the elevated HE4 levels, imaging diagnoses, and elevated cancer antigen 125 (CA125) levels in patients with recurrence. The Ethics Review Committee of our institution (2021-056) reviewed this study.
Results:
Forty-eight patients with epithelial OC were eligible for enrollment. The sensitivity, specificity, and positive and negative predictive values of HE4 (criterion, 70 pmol/L) for disease progression during the follow-up period were 79.4%, 59.1%, 32.5%, and 92.0%, respectively (time point, n=317). We evaluated the relationship between HE4 and CA125 variability and disease status (recurrence or no recurrence). For recurrence, the sensitivity and negative predictive value of HE4 (criterion, 70 pmol/L), CA125 (criterion, 35 U/mL), and combination of HE4 and CA125 were 77.8%, 85.2%, and 92.6% and 75.0%, 82.6%, and 88.9%, respectively (n=48). Among the 27 patients who exhibited recurrence, 16 and nine showed earlier increased HE4 levels than the relevant imaging and CA125 levels, respectively.
Conclusion
HE4 may be a valuable marker for follow-up during and after OC therapy. A complementary role for HE4 and CA125 measurements was suggested for follow-up observations.
2.Loiasis in a Japanese Traveler Returning from Central Africa
Tetsuro Kobayashi ; Kayoko Hayakawa ; Momoko Mawatari ; Makoto Itoh ; Nobuaki Akao ; Rie R. Yotsu ; Jun Sugihara ; Nozomi Takeshita ; Satoshi Kutsuna ; Yoshihiro Fujiya ; Shuzo Kanagawa ; Norio Ohmagari ; Yasuyuki Kato
Tropical Medicine and Health 2015;43(2):149-153
We encountered a probable case of loiasis in a returned traveler from Central Africa. A 52-year-old Japanese woman presented to our hospital complaining of discomfort in her eyes and skin. She reported having frequently visited Central Africa over many years and having been extensively exposed to the rainforest climate and ecosystem. Although no microfilariae were found in her blood, there was an elevated level of IgG antibodies against the crude antigens of Brugia pahangi, which have cross-reactivity with Loa loa. She was treated with albendazole for 21 days, after which the antigen-specific IgG level decreased and no relapse occurred.
3.Loiasis in a Japanese traveler returning from Central Africa
Tetsuro Kobayashi ; Kayoko Hayakawa ; Momoko Mawatari ; Makoto Itoh ; Nobuaki Akao ; Rie Roselyne Yotsu ; Jun Sugihara ; Nozomi Takeshita ; Satoshi Kutsuna ; Yoshihiro Fujiya ; Shuzo Kanagawa ; Norio Ohmagari ; Yasuyuki Kato
Tropical Medicine and Health 2015;advpub(0):-
We encountered a probable case ofloiasis in a returned traveler from Central Africa. A 52-year-old Japanese womanpresented to our hospital complaining of discomfort in her eyes and skin. She reportedhaving frequently visited Central Africa over many years and having been extensivelyexposed to the rainforest climate and ecosystem. Although no microfilariae werefound in her blood, there was an elevated level of IgG antibodies against thecrude antigens of Brugia pahangi,which have cross-reactivity with Loa loa.She was treated with albendazole for 21 days, after which the antigen-specificIgG level decreased and no relapse occurred.
4.Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
Tamaki TANAKA ; Kazuhiro TAKEHARA ; Natsumi YAMASHITA ; Mika OKAZAWA-SAKAI ; Kazuya KURAOKA ; Norihiro TERAMOTO ; Kenichi TAGUCHI ; Katsushige YAMASHIRO ; Hidenori KATO ; Tomoya MIZUNOE ; Rie SUZUKI ; Dan YAMAMOTO ; Arisa UEKI ; Toshiaki SAITO
Journal of Gynecologic Oncology 2022;33(5):e67-
Objective:
To clarify the frequency of deficient mismatch repair (dMMR) in Japanese ovarian cancer patients, we examined microsatellite instability (MSI) status and immunohistochemistry (IHC) subtypes, including endometrioid carcinoma (EMC), clear cell carcinoma (CCC), or a mixture of both (Mix).
Methods:
We registered 390 patients who were diagnosed with EMC/CCC/Mix between 2006 and 2015 and treated at seven participating facilities. For 339 patients confirmed eligible by the Central Pathological Review Board, MSI, IHC, and MutL homolog 1 methylation analyses were conducted. The tissues of patients with Lynch syndrome (LS)-related cancer histories, such as colorectal and endometrial cancer, were also investigated.
Results:
MSI-high (MSI-H) status was observed in 2/217 CCC (0.9%), 10/115 EMC (8.7%), and 1/4 Mix (25%). Additionally, loss of MMR protein expression (LoE-MMR) was observed in 5/219 (2.3%), 16/115 (14.0%), and 1/4 (25%) patients with CCC, EMC, and Mix, respectively. Both MSI-H and LoE-MMR were found significantly more often in EMC (p<0.001). The median (range) ages of patients with MMR expression and LoE-MMR were 54 (30–90) and 46 (22–76) (p=0.002), respectively. In the multivariate analysis, advanced stage and histological type were identified as prognostic factors.
Conclusion
The dMMR rate for EMC/CCC was similar to that reported in Western countries. In Japan, it is assumed that the dMMR frequency is higher because of the increased proportion of CCC.
5.Medical certification reduces the number of children requiring allergen elimination diets for school lunches
Seigo KOREMATSU ; Kenji TOYOKUNI ; Yousuke HANDA ; Chika GOTOH ; Rieko WASADA ; Rie KATO ; Nanae KAWANO ; Mayo IKEUCHI ; Tomoko OKAMOTO ; Maki KIRIYA ; Mizuho TAKAHASHI ; Tomoyuki TAKANO ; Atsuhiko HAIGO
Asia Pacific Allergy 2017;7(2):92-96
BACKGROUND: Following the increase in the number of children with food allergies, support systems are now required for school lunches, but a large-scale factual investigation has not been carried out. OBJECTIVE: We evaluated the features of elimination diet due to food allergy and the support system in kindergartens and schools. METHODS: A prefecture-based questionnaire survey regarding measures for food allergies in school lunches of all kindergartens, public elementary schools, and public junior high schools (631 facilities) was conducted in Oita Prefecture, Japan. RESULTS: The recovery rate of the questionnaire was 99.5%, which included 106,008 students in total. A total of 1,562 children (1.5%) required elimination diets. The rate of children on elimination diets in kindergartens and elementary/junior high schools that required medical certification by a physician was 1.2% (324 among 27,761 children), which was significantly lower than the 1.8% of children (1,227 among 68,576 students) on elimination diets at the request of guardians without the need for medical certification (p < 0.0001). A total of 43.9% of the kindergartens and schools said that they would contact guardians if symptoms were observed after accidental ingestion, while a low 8.1% stated that they provided support to children themselves, including the administration of adrenaline auto-injectors. CONCLUSION: Medical certification reduces the number of children requiring elimination diets, but it has not been adequately implemented. Furthermore, waiting to contact guardians after symptoms are observed may lead to the delayed treatment of anaphylaxis. Cooperation between physicians and teachers is desired to avoid the overdiagnosis and undertreatment of children with food allergies.
Anaphylaxis
;
Certification
;
Child
;
Diet
;
Eating
;
Epinephrine
;
Food Hypersensitivity
;
Humans
;
Japan
;
Lunch
;
Medical Overuse